NEURO NEWS
Neurological News with information about conditions, treatments, current studies and breakthroughs.
Empowering Recovery: The Role of Neuromodulation in Spinal Cord Injury Rehabilitation
In a groundbreaking study by Nicholas D James, Stephen B McMahon, Edelle C Field-Fote, and Elizabeth J Bradbury, the transformative [...]
Transcranial Magnetic Stimulation for Alcohol Craving: A Breakthrough Study
This study explores the anticraving efficacy of high-frequency repetitive transcranial magnetic stimulation (rTMS) on the right and left dorsolateral prefrontal [...]
Revolutionizing Spinal Cord Injury Recovery: The Impact of Transcranial Magnetic Brain Stimulation
In a pioneering study conducted at the National Spinal Injuries Centre and Division of Neuroscience, researchers investigated the potential of [...]
In Just a Few Days: TMS Reshaping Lives, One Session at a Time
Embark on a groundbreaking journey at Countryside Neurology as we delve into a transformative study on PTSD treatment. This trial [...]
Happy New Year!
🎉✨ Wishing Everyone a Happy and Prosperous New Year! 🌟🎆 May the coming year be filled with joy, success, and [...]
Revolutionizing Depression Treatment: Breakthroughs with Accelerated iTBS
Embark on a revolutionary journey in depression treatment with accelerated intermittent theta burst stimulation (aiTBS). This groundbreaking study, conducted in [...]
- Medicinal Signaling Cell Therapy Fast Tracked for Mild Alzheimer Disease July 29, 2024The investigational allogeneic cellular therapy is believed to impart anti-inflammatory, pro-vascular, and pro-regenerative effects.
- Endo Recalls Clonazepam ODT Due to Carton Label Displaying Incorrect Strength July 29, 2024The product is being recalled because the incorrect strength of 0.125mg is appearing on the carton labels.
- Investigational Gene Therapy for Parkinson Disease Gets Fast Track Status July 22, 2024AB-1005 is an investigational gene therapy based on AAV2 containing the human GDNF transgene.
- FDA Approves Aflibercept Biosimilar Ahzantive July 16, 2024Ahzantive is a vascular endothelial growth factor inhibitor.
- Ketamine May Reduce Cluster Headache Symptoms July 2, 2024Researchers sought to evaluate ketamine as a potentially promising treatment approach.
Get Social